Here we provide a comprehensive summary of the data relating to the incidence of uveitis flares in CZP‐treated patients with axial SpA from the RAPID‐axSpA trial; this is the first study to explore the effects of an anti‐TNF on comorbid uveitis in the broad population of patients with axial SpA, including AS and nr‐axial SpA patients. This evidence concerns the gene TNF and uveitis.